Nonetheless, Melchiorre et al. demonstrated that using anti-TNFα [46] therapy to treat concurrent autoimmune disease (RA or psoriasis) symptoms in three patients with underlying hemophilic arthropathy decreased synovitis and greatly decreased the frequency of hemarthroses. The gene discussed is TNF; the disease is psoriasis.